Article
Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse…
Cancer Management and Research · 2018 · Asby DJ, Killick-Cole CL, Boulter LJ, Singleton WGB, Asby CA, Wyatt MJ, Barua NU, Bienemann AS, Gill SS
Key facts
| Title | Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity |
|---|---|
| First author | Asby DJ, Killick-Cole CL, Boulter LJ, Singleton WGB, Asby CA, Wyatt MJ, Barua NU, Bienemann AS, Gill SS |
| Journal | Cancer Management and Research |
| Published | Sep 12, 2018 |
| DOI | 10.2147/CMAR.S167095 |
| Devices mentioned | BK110039 |
| Product codes mentioned | KIP, KIT, MVU, NDS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1